Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside
I Martynov, L Dhaka, B Wilke, P Hoyer… - Frontiers in …, 2024 - frontiersin.org
Background Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue
malignancy, characterized by high clinicalopathological and molecular heterogeneity …
malignancy, characterized by high clinicalopathological and molecular heterogeneity …
IL-4 Downregulates PD-L1 Level Via SOCS1 Upregulation-Induced JNK Deactivation to Enhance Antitumor Immunity in In Vitro Colorectal Cancer
R Huang, B Zhang, W Ye, Z Tang… - Journal of Interferon & …, 2024 - liebertpub.com
Interleukin-4 (IL-4) controls cell growth and immune system regulation in tumorigenesis and
can inhibit the growth of colon cancer cell lines, but the possible mechanism is unclear. In …
can inhibit the growth of colon cancer cell lines, but the possible mechanism is unclear. In …
Developmental and therapeutic implications of IL4ra expression for rhabdomyosarcoma
DW Edwards, GM Kroepfl, JM Jackson, S Chen… - Transgenic …, 2024 - Springer
Rhabdomyosarcoma (RMS) is a solid tumor whose metastatic progression can be
accelerated through interleukin-4 receptor alpha (Il4ra) mediated interaction with normal …
accelerated through interleukin-4 receptor alpha (Il4ra) mediated interaction with normal …